(Q37999935)

26 August 2017

1 reference

title

Psychotropic drug use in the medically ill: Part I. (English)

1 reference

26 August 2017

Stoudemire A

1

1 reference

26 August 2017

Moran MG

series ordinal

2

1 reference

26 August 2017

Fogel BS

series ordinal

3

1 reference

26 August 2017

publication date

1 January 1990

1 reference

26 August 2017

1 reference

26 August 2017

volume

31

1 reference

26 August 2017

issue

4

1 reference

26 August 2017

page(s)

377-391

1 reference

Psychotropic drug interactions in the patient with late-onset psychosis and mood disorder. Part 1.

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Treatment guidelines for psychotropic drug use in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Cardiac Antiarrhythmic Effect of Imipramine Hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Tricyclic antidepressants in depressed patients with cardiac conduction disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Use of cyclic antidepressants in patients with cardiac conduction disturbances

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Psychiatric aspects of patients with malignant ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

QT interval prolongation as predictor of sudden death in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Ventricular arrhythmias possibly aggravated by trazodone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Complete heart block following a single dose of trazodone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Fluoxetine: a serotonin-specific, second-generation antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Evaluation of bupropion hydrochloride: the first of a new class of atypical antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Effects of encainide, flecainide, imipramine and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Cardiac arrhythmia following rapid imipramine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Rebound antidepressant cardiac arrhythmia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

The effect of tricyclic antidepressants on ventricular fibrillation and collateral blood supply following acute coronary occlusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

The use of imipramine in depressed patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Plasma levels and effects of nortriptyline in geriatric depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Orthostatic effect of imipramine and doxepin in depressed geriatric outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Comparison of imipramine- and nortriptyline-induced orthostatic hypotension: a meaningful difference.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Use of tricyclic antidepressants in patients with glaucoma. Assessment and appropriate precautions

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Nortriptyline treatment of post-stroke depression: a double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Adverse reactions to tartrazine

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Allergy to tartrazine in antidepressants.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Antidepressants and convulsive seizures: clinical, electroencephalographic, and pharmacological aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Relationship between age and tricyclic antidepressant plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Concentrations of desipramine in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Desipramine plasma concentration and therapeutic response in elderly depressives: a naturalistic pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Nortriptyline metabolism in chronic renal failure: metabolite elimination

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Tricyclic antidepressant and metabolite levels in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Plasma-nortriptyline levels in endogenous depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

High plasma nortriptyline levels in the treatment of depression. I

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Nortriptyline plasma levels and therapeutic response

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

L-deprenyl in Alzheimer's disease. Preliminary evidence for behavioral change with monoamine oxidase B inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Treatment of depression in Huntington's disease with monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Efficacy of phenelzine in geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Pharmacokinetics of tranylcypromine in patients who are depressed: relationship to cardiovascular effects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Vasopressor challenges during chronic MAOI or TCA treatment in anesthetized dogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Comparative effects of seven antidepressant regimes on appetite, weight and carbohydrate preference

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Monoamine oxidase inhibitors and anaesthesia. A review

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Monoamine oxidase inhibitors revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Danger of MAOI therapy after fluoxetine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Danger of MAOI therapy after fluoxetine withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

What is the degree of risk of hepatotoxicity for depressed patients receiving phenelzine therapy? Is the risk sufficient to require that we modify the written advice (as to diet and risks) that we regularly give our patients before we institute this

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Effect of some monoamine oxidase inhibitors on the thiamin status of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Monoamine oxidase inhibitors as treatment for depressed patients with primary degenerative dementia (Alzheimer's disease).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Drug therapy: Psychotropic drug use in the elderly (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Benzodiazepines in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Benzodiazepine kinetics: implications for therapeutics and pharmacogeriatrics

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Clorazepate and lorazepam: clinical improvement and rebound anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Traveler's amnesia. Transient global amnesia secondary to triazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

The effects of age and liver disease on the disposition and elimination of diazepam in adult man

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Effect of diazepam on ventilatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Buspirone, an anxiolytic drug that stimulates respiration

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Pharmacokinetics of buspirone in elderly subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Idiosyncratic pharmacokinetics complicating treatment of major depression in an elderly woman.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

Yohimbine- and tranylcypromine-induced postural hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS0033-3182%2890%2972132-9

7 January 2021

10.1016/S0033-3182(90)72132-9

Identifiers

DOI

0 references

1 reference